The Lancet analysis on using HRT to treat menopause symptoms shows the risk of ovarian cancer disappears soon after therapy ceases. Women who use HRT for five years or more do have an increased ovarian cancer risk. However, most women only need to use HRT for 2-3 years and escape the cancer risk.